Modified chemotherapy regimen for Hodgkin lymphoma reduces long-term side effects

A simple change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts that can result from treatment, according to researchers in Cambridge.

Bristol Myers makes a $4.8B bet on KRAS, striking deal to acquire Mirati

Bristol Myers Squibb has signed a $4.8 billion deal to buy Mirati Therapeutics and its cancer drug Krazati, which targets what was once thought to

October 9, 2023

A father dreamed of a home for his family. Medical debt nearly pushed them onto the streets.

Kayce Atencio used to be haunted by a thought while working at a homeless shelter in downtown Denver. “It could have been me,” said Atencio,

September 11, 2023

In Gaza, the Glia Project 3D prints tourniquets and stethoscopes

Tarek Loubani looked around at his fellow doctors at Al Shifa Hospital in Gaza City and realized he held one of just two stethoscopes in

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.